e-learning
resources
Milan 2017
Sunday, 10.09.2017
Rare diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The Italian Reference Center Database for Pulmonary Alveolar Proteinosis (PAP).
I. Campo (Pavia, Italy)
Source:
International Congress 2017 – Rare diseases
Session:
Rare diseases
Session type:
Poster Discussion
Number:
1509
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Campo (Pavia, Italy). The Italian Reference Center Database for Pulmonary Alveolar Proteinosis (PAP).. 1509
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
Surfactant protein expression at various COPD Gold stages
Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury
Related content which might interest you:
The natural history of Pulmonary Alveolar Proteinosis (PAP): data from the Italian National Reference Center
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Clinical characteristics of familial Idiopathic Pulmonary Fibrosis (f-IPF) at the University of Giessen Marburg Lung Center.
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Cystic fibrosis. Lung Biology in Health Disease, Vol. 242.
Source: Eur Respir Rev 2010 19: 352-353
Year: 2010
Interventional Pulmonary Medicine. Lung Biology in Health and Disease
Source: Eur Respir J 2005; 25: 583
Year: 2005
Pulmonary Alveolar Microlithiasis: From Diagnosis to Transplant: An Indian Experience
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Evaluation of the Integrated Tuberculosis Research Programme (PII TB) by SEPAR (Spanish Respiratory Society)
Source: International Congress 2019 – Tuberculosis: a public health approach
Year: 2019
European pulmonary alveolar proteinosis network (EuPAPNet): Results from biomarkers´ investigation
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
Book Review: Pulmonary Hypertension
Source: Eur Respir Rev 2012 21: 372
Year: 2012
LATE-BREAKING ABSTRACT: Epidemiology of IPF in Italy
Source: International Congress 2014 – ILDs 6
Year: 2014
Childhood Interstitial Lung disease: A Tertiary Single Center Experience
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Clinical features of four children with pulmonary alveolar proteinosis
Source: International Congress 2014 – ILDs 5
Year: 2014
Choir in the Pulmonary Rehabilitation Program
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017
Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Implementation of FAST strategy in the National Center for Tuberculosis and Lung Diseases (NCTLD) in Georgia
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Dedicated Pulmonary Rehabilitation for Patients with Interstitial Lung Disease in a District General Hospital
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept